What Does the NIN Study Show About Diet Quality and Rheumatoid Arthritis Risk in India?

A 2026 case-control study from the ICMR-National Institute of Nutrition (ICMR-NIN) in Hyderabad found that adults newly diagnosed with rheumatoid arthritis had a median Dietary Inflammatory Index (DII) score of 2.18 — nearly six times the 0.37 recorded among healthy controls — and substantially lower dietary diversity and micronutrient adequacy. The findings point to a significant association between overall diet quality and RA risk in an urban Indian population. Published in the peer-reviewed journal Nutrients, the study is among the first of its scale to examine these three diet-quality dimensions simultaneously in Indian adults.

The numbers across all three measures tell a consistent story. The table below summarises the headline findings:

Diet-Quality Measure	RA Patients (n = 301)	Healthy Controls (n = 314)	Adjusted Odds Ratio per Unit Change
Dietary Inflammatory Index (DII) — median score	2.18	0.37	AOR 1.17 (95% CI: 1.10–1.24) per 1-unit increase → 17% higher odds of RA
High Dietary Diversity Score (DDS) — % of group	50.2%	74.2%	AOR 0.73 (95% CI: 0.66–0.81) per 1-unit increase → 27% lower odds of RA
Mean Probability of Adequacy (MPA) — median %	18.9%	32.9%	AOR 0.88 (95% CI: 0.83–0.94) per 10-percentage-point increase → 12% lower odds of RA

Sources: MDPI Nutrients (peer-reviewed paper); The Hindu; medRxiv preprint

All odds ratios were adjusted for age, sex, and body mass index. The direction of association is the same across all three measures: a more inflammatory diet, less diversity, and poorer micronutrient coverage each independently track with higher odds of having RA.

What exactly is rheumatoid arthritis, and why does diet matter?

Rheumatoid arthritis is a chronic systemic autoimmune disease characterised by persistent synovial inflammation, progressive joint destruction, pain, swelling, and reduced mobility. Unlike osteoarthritis, which is primarily a wear-and-tear condition, RA involves the immune system mistakenly attacking healthy joint tissue — a different disease in both mechanism and treatment approach.

RA affects approximately 0.5–1% of the global population and occurs two to three times more frequently in women than men, typically manifesting during middle adulthood. NIN researchers cite incidence estimates of 20 to 40 new cases per 100,000 people per year in India, with women disproportionately represented — a pattern reflected in the study itself, where roughly 89% of participants were women.

RA pathogenesis involves both genetic susceptibility (particularly the HLA-DRB1 gene) and environmental triggers including cigarette smoking, infections, and dietary factors. Diet is thought to modulate inflammation — the central driver of RA — through its effects on immune regulation, oxidative stress, gut microbiota composition, and inflammatory cytokine production. Diets rich in vegetables, fruits, pulses, and nuts supply antioxidants and fermentable fibre that feed gut bacteria producing anti-inflammatory short-chain fatty acids. Conversely, diets high in refined carbohydrates, saturated fats, and processed foods are linked to systemic low-grade inflammation that may lower the threshold for autoimmune activation.

Despite this biological plausibility, the specific role of dietary patterns in Indian RA populations had not been extensively studied before this ICMR-NIN work. Most prior evidence came from Western cohorts with very different dietary baselines.

How was the ICMR-NIN study designed and who was enrolled?

The study used an unmatched case-control design, enrolling 615 adults aged 18 to 55 years from Hyderabad between 2014 and 2015 (ethics approvals: NIN IEC 03/01/2014; NIMS IEC EC/NIMS/1665/2015). Of these, 301 were newly diagnosed RA patients and 314 were healthy controls. Recruiting newly diagnosed patients was a deliberate methodological choice: it reduces — though cannot eliminate — the risk that the disease itself or its drug treatment had already altered participants' eating habits before data collection.

Dietary intake was assessed using a validated 131-item food frequency questionnaire (FFQ) covering the previous twelve months. The FFQ captured habitual intake across foods typical of urban Hyderabadi diets, from cereals and pulses to dairy, meat, fruits, vegetables, nuts, and processed foods.

Three distinct diet-quality metrics were then calculated from the FFQ data:

The Dietary Inflammatory Index (DII) scores a diet according to the known pro- or anti-inflammatory effects of its components, drawing on a large body of experimental and epidemiological literature. A higher positive score indicates a more pro-inflammatory diet.
The Dietary Diversity Score (DDS) counts how many of ten defined food groups — including pulses, dairy, leafy vegetables, fruits, and nuts — a person regularly consumes. Higher scores indicate greater variety.
The Mean Probability of Adequacy (MPA) estimates the probability that a diet meets requirements for ten key micronutrients, expressed as a percentage where higher values indicate better micronutrient coverage.

Blood samples were also collected to measure rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies by ELISA — two hallmark autoantibodies used in RA diagnosis and monitoring. Multivariable logistic regression models adjusted for age, sex, and BMI were used to calculate adjusted odds ratios. Population attributable fractions (PAFs) were estimated under a theoretical causal framework as an exploratory exercise.

What were the main findings on inflammatory diet potential?

The DII gap between groups was striking. RA patients recorded a median DII of 2.18 compared to 0.37 among healthy controls, meaning the average RA patient's diet carried substantially greater inflammatory potential. After adjustment for age, sex, and BMI, each one-unit increase in DII was associated with 17% higher odds of RA (AOR 1.17; 95% CI: 1.10–1.24).

When the researchers analysed DII in thirds rather than as a continuous variable, the contrast sharpened further: people in the highest third had approximately two and a half times the odds of RA compared to those in the lowest third. This dose-response pattern — where the association strengthens as the exposure increases — is generally considered more convincing evidence of a real relationship, though it still cannot establish causation in a case-control design.

The pro-inflammatory dietary pattern typical of RA patients in this sample likely reflected higher intakes of refined carbohydrates, saturated and trans fats, and processed foods, consistent with the ongoing nutrition transition in urban India. Rapid urbanisation has shifted Indian diets away from traditional plant-heavy patterns toward more energy-dense, processed-food-heavy eating — a shift that NIN researchers note may be contributing to chronic inflammatory conditions.

What did the study find about dietary diversity and micronutrient adequacy?

The diversity and micronutrient findings reinforced the DII picture from the opposite direction. Only 50.2% of RA patients had a high dietary diversity score, compared with 74.2% of healthy controls — a gap of nearly 24 percentage points. Each additional food group consumed was associated with 27% lower odds of RA (AOR 0.73; 95% CI: 0.66–0.81).

Micronutrient adequacy told a similar story. Median MPA was 18.9% among RA cases against 32.9% among controls: the average RA patient's diet was estimated to meet requirements for fewer than two of the ten assessed micronutrients, while the average control's diet met requirements for roughly three. Each 10-percentage-point increase in MPA was linked to 12% lower odds of RA (AOR 0.88; 95% CI: 0.83–0.94).

These findings are consistent with what is known about specific micronutrients and inflammation. Vitamins C, D, and E, along with zinc, selenium, and omega-3 fatty acids, have established roles in immune regulation and antioxidant defence. Diets low in diversity tend to be disproportionately cereal-heavy, which in the Indian context often means adequate calories but poor coverage of these immune-relevant micronutrients.

Study supervisor Dr Devraj J. Parasannanavar summarised the implication: "The findings point towards the importance of looking at overall dietary quality rather than individual nutrients in understanding chronic inflammatory conditions. Dietary diversity and adequate intake of essential micronutrients are important components of a healthy diet, and their potential relationship with inflammatory diseases warrants further investigation."

Did the study find any link between diet and RA autoantibodies?

The relationship between diet quality and RA-related autoantibodies was more complex and less consistent than the relationship with RA diagnosis itself. Higher dietary diversity, when analysed as a continuous variable, was associated with lower anti-CCP antibody concentrations, but this association did not hold for rheumatoid factor (RF). Continuous DII and MPA were not significantly associated with either anti-CCP or RF, and associations across categorical analyses were inconsistent.

Anti-CCP antibodies are considered a more specific marker of RA than RF, and their presence is associated with more aggressive disease. The partial association between dietary diversity and anti-CCP — but not RF — may reflect different pathogenic pathways for seropositive versus seronegative RA, or simply limited statistical power to detect autoantibody associations.

The medRxiv preprint version (posted November 2025, before peer review) reported that high DDS and adequate micronutrient adequacy were associated with lower RF and anti-CCP levels, but the peer-reviewed Nutrients paper describes these autoantibody associations as "limited and inconsistent". This discrepancy between preprint and final publication is worth noting — it illustrates how peer review can refine and sometimes temper initial findings.

What are the population attributable fractions, and what do they mean?

As an exploratory exercise, the research team estimated population attributable fractions (PAFs) — a measure of how much of the disease burden in the study sample was statistically associated with each dietary risk factor. The estimated PAFs were 43.8% for higher DII, 39.5% for low DDS, and 37.5% for nutrient inadequacy.

These numbers are striking, but the authors explicitly warn against over-interpreting them. PAFs in a case-control study under a theoretical causal framework do not mean that 44% of RA cases would be prevented if everyone ate an anti-inflammatory diet. The dietary factors overlap substantially with each other — a person eating a diverse diet is also likely to have better micronutrient adequacy and a lower DII — so the fractions cannot simply be added together. The case-control design cannot establish that diet preceded disease onset, either.

The PAFs are best understood as a quantitative expression of how strongly diet and RA co-occur in this sample, and as a tool for prioritising which dietary dimensions deserve investigation in prospective studies.

How does this study compare with international evidence?

The ICMR-NIN findings align with, and extend, a body of international research. A landmark Harvard prospective study following 76,597 women in the Nurses' Health Study and 93,392 in the Nurses' Health Study II found that long-term adherence to a healthy eating pattern (measured by the Alternative Healthy Eating Index 2010) was associated with lower RA risk among women aged 55 or younger — particularly for seropositive RA (HR 0.60; 95% CI: 0.42–0.86 for the highest versus lowest diet-quality quartile). That study had the advantage of a prospective design, which can better address the question of temporal sequence.

The NIN study adds several dimensions the Harvard work did not capture: it uses the DII to quantify inflammatory potential specifically, it assesses dietary diversity across food groups rather than a composite healthy-eating score, and it does so in an Indian population with a very different dietary baseline. Indian diets are frequently dominated by cereals, with limited fruit, vegetables, pulses, and dairy in many households — a pattern that NIN's own national dietary guidelines have repeatedly flagged as a public health concern.

The Mediterranean diet, rich in vegetables, fruits, whole grains, legumes, fish, and olive oil, has been associated in multiple studies with reduced RA disease activity and improved physical function. Its anti-inflammatory properties overlap substantially with what the NIN study identifies as protective: high diversity, adequate micronutrients, and low inflammatory potential. The challenge for Indian public health is translating these principles into culturally appropriate, affordable dietary guidance for a population where the nutrition transition is actively reshaping eating habits.

What are the key limitations of the study?

The authors are unusually candid about what their study cannot show, and those limitations deserve careful attention.

The most fundamental constraint is the case-control design. Comparing people who already have RA with people who do not cannot establish which came first — the dietary pattern or the disease. This is the problem of reverse causation: early, undiagnosed RA symptoms (fatigue, reduced appetite, pain affecting food preparation) might have changed patients' diets before formal diagnosis, making poor diet appear to precede RA when it may partly be a consequence of it. Recruiting newly diagnosed patients reduces this risk but does not eliminate it.

Cases and controls were recruited from different settings — RA patients from a rheumatology clinic, controls from the community — and differed in age and BMI before adjustment. Diet was self-reported and recalled over a year, introducing the well-documented limitations of dietary recall. The analysis could not account for smoking, socioeconomic status, physical activity, medication use, or genetics, all of which influence RA risk independently of diet.

The study was conducted in a single southern Indian city, limiting generalisability to other regions with different dietary traditions. The cross-sectional snapshot of diet captured by the FFQ also cannot reflect how eating habits may have changed over a lifetime.

ICMR-NIN Director Dr Bharati Kulkarni called for "long-term and intervention-based studies to determine whether dietary improvements can help prevent or modify RA," adding that the findings "should be interpreted cautiously."

What practical implications does the study have for Indian diets and RA?

While the study cannot tell patients that changing their diet will prevent or treat RA, its findings carry practical relevance at both the individual and public health levels.

For individuals, the dietary patterns associated with lower RA odds in this study — greater variety across food groups, adequate micronutrient intake, and lower inflammatory potential — are consistent with general healthy eating guidelines and carry no meaningful downside risk. A diet that includes more pulses, leafy vegetables, fruits, dairy, and nuts alongside reduced refined carbohydrates and processed foods benefits cardiovascular, metabolic, and gut health regardless of its effect on RA. For people already diagnosed with RA, evidence on Mediterranean-style anti-inflammatory diets suggests potential benefits for disease activity and physical function, though those findings come from different populations and study designs.

At the public health level, the study provides Indian data — from Indian diets, in an Indian city — to inform the design of prospective cohort studies and dietary intervention trials that could answer the causation question. If such trials confirm that improving diet quality reduces RA incidence or modifies disease course, dietary advice could become a low-cost, accessible complement to pharmacological treatment, which remains the cornerstone of RA management.

The nutrition transition in urban India — away from diverse, plant-heavy traditional diets toward more processed, refined, and energy-dense foods — is a documented trend that NIN has flagged in multiple national nutrition surveys. This study suggests that trend may carry consequences for autoimmune disease risk, not just for the metabolic conditions more commonly associated with poor dietary quality.

For readers interested in related nutritional approaches to inflammation and joint health, evidence on natural supplements for knee arthritis pain and algae-based omega-3 DHA for vegetarians — nutrients with established anti-inflammatory properties — may provide useful complementary context.

What research is needed next?

The study's authors, its institutional director, and the broader scientific logic all point to the same next step: prospective cohort studies and randomised dietary intervention trials. A prospective study would follow people over time, measuring diet before any RA diagnosis, and could establish whether dietary patterns predict future disease onset — directly addressing the reverse causation problem the case-control design cannot resolve.

Intervention trials would go further, randomly assigning participants to different dietary patterns and measuring RA-related outcomes including autoantibody levels, inflammatory markers, and clinical disease activity. Such trials are logistically complex and expensive, but they are the only design that can establish whether dietary change causes improvement in RA risk or outcomes.

The ICMR-NIN study provides the epidemiological rationale and the Indian dietary data needed to design such trials. Its three-dimensional approach — measuring inflammatory potential, diversity, and micronutrient adequacy simultaneously — offers a richer framework than studies focused on single nutrients or foods. The finding that all three dimensions point in the same direction strengthens the case for a full dietary quality approach rather than a search for any single protective food or nutrient.

The study has been published in Nutrients, an international peer-reviewed journal, under the special issue "Advances in Nutrition for Autoimmune and Inflammatory Diseases." An earlier preprint version was posted on medRxiv in November 2025 before peer review. The research was funded by the Department of Health Research, Ministry of Health and Family Welfare, under a grant examining the correlation of Prakriti (ayurgenomics) with dietary patterns, gut microbiota, HLA-DRB1 genes, and disease severity in RA patients — a broader research programme that situates this dietary analysis within a wider investigation of RA's multifactorial origins.